Li Dean Y
Insider CIK 1837016 · RXRX Director · MRK Executive VP & President, MRL
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2026-10-01 | 2026-10-02 | 3,378 | — | $0 | 1,476,707 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2026-07-01 | 2026-07-02 | 3,747 | — | $0 | 1,473,329 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2026-06-17 | 2026-06-22 | 88,424 | — | $0 | 1,469,582 | SEC↗ |
| MRK Merck & Co., Inc. | A Award deriv | 2026-05-05 | 2026-05-07 | 19,885 | — | $0 | 19,885 | SEC↗ |
| MRK Merck & Co., Inc. | A Award deriv | 2026-05-05 | 2026-05-07 | 58,207 | — | $0 | 58,207 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise deriv | 2026-04-29 | 2026-05-01 | 4,722 | — | $0 | 9,444 | SEC↗ |
| MRK Merck & Co., Inc. | F Tax w/h | 2026-04-29 | 2026-05-01 | 2,326 | $110.03 | $255.9K | 94,431 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise | 2026-04-29 | 2026-05-01 | 4,722 | $110.03 | $519.6K | 96,757 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2026-04-01 | 2026-04-02 | 3,268 | — | $0 | 1,244,177 | SEC↗ |
| MRK Merck & Co., Inc. | S Sale | 2026-02-10 | 2026-02-10 | 10,235 | $117.52 | $1.20M | 92,035 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise deriv | 2026-02-04 | 2026-02-06 | 15,087 | — | $0 | 0 | SEC↗ |
| MRK Merck & Co., Inc. | S Sale | 2026-02-04 | 2026-02-06 | 15,087 | $118.77 | $1.79M | 102,270 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise | 2026-02-04 | 2026-02-06 | 15,087 | $56.04 | $845.5K | 117,357 | SEC↗ |
| MRK Merck & Co., Inc. | A Award | 2026-01-26 | 2026-01-28 | 20,469 | $107.40 | $2.20M | 102,270 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2026-01-02 | 2026-01-06 | 2,381 | — | $0 | 1,240,909 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-10-01 | 2025-10-03 | 1,961 | — | $0 | 1,238,528 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-07-01 | 2025-07-03 | 1,949 | — | $0 | 1,236,567 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2025-06-18 | 2025-06-23 | 44,031 | — | $0 | 44,031 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-06-18 | 2025-06-23 | 22,016 | — | $0 | 1,234,618 | SEC↗ |
| MRK Merck & Co., Inc. | A Award deriv | 2025-04-29 | 2025-05-01 | 64,481 | — | $0 | 64,481 | SEC↗ |
| MRK Merck & Co., Inc. | A Award deriv | 2025-04-29 | 2025-05-01 | 14,166 | — | $0 | 14,166 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-04-01 | 2025-04-03 | 2,268 | — | $0 | 79,618 | SEC↗ |
| MRK Merck & Co., Inc. | A Award | 2025-01-27 | 2025-01-29 | 32,621 | $97.94 | $3.19M | 79,592 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-01-02 | 2025-01-06 | 1,647 | — | $0 | 77,350 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-10-01 | 2024-10-04 | 1,925 | — | $0 | 75,703 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-07-01 | 2024-07-03 | 1,592 | — | $0 | 73,778 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2024-06-03 | 2024-06-05 | 26,193 | — | $0 | 26,193 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-06-03 | 2024-06-05 | 13,097 | — | $0 | 72,186 | SEC↗ |
| MRK Merck & Co., Inc. | A Award deriv | 2024-04-30 | 2024-05-02 | 65,625 | — | $0 | 65,625 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-04-01 | 2024-04-03 | 1,267 | — | $0 | 59,089 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise deriv | 2024-02-09 | 2024-02-12 | 14,702 | — | $0 | 0 | SEC↗ |
| MRK Merck & Co., Inc. | S Sale | 2024-02-09 | 2024-02-12 | 14,702 | $125.50 | $1.85M | 46,242 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise | 2024-02-09 | 2024-02-12 | 14,702 | $62.07 | $912.6K | 60,944 | SEC↗ |
| MRK Merck & Co., Inc. | A Award | 2024-01-22 | 2024-01-24 | 25,760 | $119.43 | $3.08M | 46,242 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-01-09 | 2024-01-11 | 28,038 | $13.65 | $382.7K | 421,962 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2024-01-09 | 2024-01-11 | 962 | $14.03 | $13.5K | 421,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-01-02 | 2024-01-04 | 1,203 | — | $0 | 1,327,618 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-10-02 | 2023-10-04 | 1,659 | — | $0 | 1,326,415 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-07-03 | 2023-07-06 | 1,609 | — | $0 | 637,461 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2023-06-16 | 2023-06-21 | 25,224 | — | $0 | 25,224 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-06-16 | 2023-06-21 | 12,612 | — | $0 | 636,021 | SEC↗ |
| MRK Merck & Co., Inc. | A Award deriv | 2023-05-02 | 2023-05-04 | 77,455 | — | $0 | 77,455 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise deriv | 2023-05-01 | 2023-05-03 | 1,062 | — | $0 | 0 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise | 2023-05-01 | 2023-05-03 | 1,062 | $115.47 | $122.6K | 20,995 | SEC↗ |
| MRK Merck & Co., Inc. | F Tax w/h | 2023-05-01 | 2023-05-03 | 524 | $115.47 | $60.5K | 20,471 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | G Gift | 2023-04-21 | 2023-10-04 | 627,705 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-04-03 | 2023-04-05 | 1,724 | — | $0 | 623,409 | SEC↗ |
| MRK Merck & Co., Inc. | A Award | 2023-01-23 | 2023-01-25 | 3,275 | $109.88 | $359.9K | 19,933 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-01-03 | 2023-01-05 | 1,573 | — | $0 | 621,685 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-10-03 | 2022-10-05 | 1,092 | — | $0 | 620,112 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-07-01 | 2022-07-06 | 1,409 | — | $0 | 619,020 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2022-06-14 | 2022-06-16 | 36,290 | — | $0 | 36,290 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-06-14 | 2022-06-16 | 18,145 | — | $0 | 617,611 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise deriv | 2022-05-03 | 2022-05-04 | 773 | — | $0 | 0 | SEC↗ |
| MRK Merck & Co., Inc. | A Award deriv | 2022-05-03 | 2022-05-05 | 75,728 | — | $0 | 75,728 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise | 2022-05-03 | 2022-05-04 | 773 | $87.65 | $67.8K | 16,839 | SEC↗ |
| MRK Merck & Co., Inc. | F Tax w/h | 2022-05-03 | 2022-05-04 | 381 | $87.65 | $33.4K | 16,458 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise deriv | 2022-05-01 | 2022-05-03 | 1,061 | — | $0 | 1,062 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise | 2022-05-01 | 2022-05-03 | 1,061 | $88.69 | $94.1K | 16,589 | SEC↗ |
| MRK Merck & Co., Inc. | F Tax w/h | 2022-05-01 | 2022-05-03 | 523 | $88.69 | $46.4K | 16,066 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-04-01 | 2022-04-05 | 1,544 | — | $0 | 599,466 | SEC↗ |
| MRK Merck & Co., Inc. | A Award | 2022-02-24 | 2022-02-28 | 3,023 | $73.51 | $222.2K | 15,462 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-01-03 | 2022-01-05 | 659 | — | $0 | 597,922 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-12-07 | 2021-12-09 | 14,900 | $20.44 | $304.6K | 1,316,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-12-07 | 2021-12-09 | 1,000 | $21.06 | $21.1K | 1,315,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-11-19 | 2021-11-19 | 13,474 | $20.20 | $272.2K | 578,163 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-11-19 | 2021-12-09 | 13,474 | $20.20 | $272.2K | 1,330,900 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-11-17 | 2021-11-19 | 5,626 | $20.04 | $112.7K | 591,637 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2021-11-17 | 2021-12-09 | 5,626 | $20.04 | $112.7K | 1,344,374 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-10-01 | 2021-10-05 | 543 | — | $0 | 597,263 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-07-01 | 2021-07-06 | 330 | — | $0 | 596,720 | SEC↗ |
| MRK Merck & Co., Inc. | A Award deriv | 2021-05-04 | 2021-05-06 | 91,837 | — | $0 | 91,837 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise deriv | 2021-05-04 | 2021-05-06 | 694 | — | $0 | 0 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise | 2021-05-04 | 2021-05-06 | 694 | $75.98 | $52.7K | 12,548 | SEC↗ |
| MRK Merck & Co., Inc. | F Tax w/h | 2021-05-04 | 2021-05-06 | 238 | $75.98 | $18.1K | 12,310 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise deriv | 2021-05-03 | 2021-05-04 | 750 | — | $0 | 750 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise | 2021-05-03 | 2021-05-04 | 750 | $74.50 | $55.9K | 12,111 | SEC↗ |
| MRK Merck & Co., Inc. | F Tax w/h | 2021-05-03 | 2021-05-04 | 257 | $74.50 | $19.1K | 11,854 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise deriv | 2021-05-01 | 2021-05-04 | 1,030 | — | $0 | 2,060 | SEC↗ |
| MRK Merck & Co., Inc. | F Tax w/h | 2021-05-01 | 2021-05-04 | 354 | $74.50 | $26.4K | 11,361 | SEC↗ |
| MRK Merck & Co., Inc. | M Exercise | 2021-05-01 | 2021-05-04 | 1,030 | $74.50 | $76.7K | 11,715 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 27,778 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 27,778 | — | $0 | 27,778 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 22,698 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 32,685 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-22 | 55,383 | — | $0 | 1,422,048 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 450,000 | — | $0 | 450,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 13,889 | — | $0 | 596,390 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 13,889 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 1,350,000 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 582,501 | — | $0 | 582,501 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 582,501 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 1,350,000 | — | $0 | 1,350,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 1,422,048 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 1,422,048 | — | $0 | 1,422,048 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 450,000 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-04-16 | 2021-04-19 | 13,889 | — | $0 | 596,390 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2021-04-15 | 2021-04-19 | 27,778 | — | $0 | 27,778 | SEC↗ |
| MRK Merck & Co., Inc. | A Award | 2021-02-26 | 2021-03-02 | 3,485 | $72.62 | $253.1K | 10,655 | SEC↗ |